Stock listing

NB3 Stock Price, News, Filings & Events — Neurocrine Biosciences, Inc.

Selected listing: NB3 · TRADEGATE · EUR · DE

NB3:TRADEGATE represents Neurocrine Biosciences, Inc., a biopharmaceutical company dedicated to developing treatments for neurological and endocrine disorders. With a significant market capitalization of around €17.67 billion, Neurocrine is focused on advancing innovative therapies to enhance patient outcomes. Recent news and filings highlight the company's ongoing commitment to research and development in this critical healthcare sector. Investors can stay informed about upcoming events and market developments related to Neurocrine's progress and initiatives.

NB3:TRADEGATEEURDEUpdated July 24, 2026
Neurocrine Biosciences, Inc. logo
Ticker
NB3:TRADEGATE
Asset type
Stock
Market cap
$17.67B
Sector
Health Technology
Industry
Biotechnology
Exchange
TRADEGATE
Currency
EUR

Neurocrine Biosciences, Inc. NB3:TRADEGATE stock context

NB3:TRADEGATE represents Neurocrine Biosciences, Inc., a biopharmaceutical company dedicated to developing treatments for neurological and endocrine disorders. With a significant market capitalization of around €17.67 billion, Neurocrine is focused on advancing innovative therapies to enhance patient outcomes. Recent news and filings highlight the company's ongoing commitment to research and development in this critical healthcare sector. Investors can stay informed about upcoming events and market developments related to Neurocrine's progress and initiatives.

Research Neurocrine Biosciences, Inc.

Alternate listings